Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
941.20Prev. Close
941.20Volume
9,158Total traded value
0.85 CrUpper Circuit
1,129.40Lower Circuit
753.00Fundamentals
| Market Cap | ₹1,980Cr |
| ROE | 12.06% |
| P/E Ratio(TTM) | 30.39 |
| EPS(TTM) | 30.92 |
| P/B Ratio | 3.91 |
| Dividend Yield | 0.61% |
| Industry P/E | 34.91 |
| Book Value | 239.99 |
| Debt to Equity | 0.06 |
| Face Value | 5 |
Understand Fundamentals
Financials
About Windlas Biotech
Windlas Biotech is a leading Contract Development and Manufacturing Organisation (CDMO) in the generic formulations sector, providing integrated and affordable healthcare solutions focused on quality. The company's operations are guided by a performance mindset rooted in consistency, which defines its approach to growth, value delivery, and creating long-term impact. Demonstrating its resilient business model, the company has achieved a significant milestone by marking nine consecutive quarters of record-breaking revenue and sustained operating margins.;
| Parent Organisation | Windlas Biotech |
| NSE Symbol | WINDLAS |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.78 | ||
| Gland Pharma | NA (0.00%) | 41.01 | ||
| Ajanta Pharma | NA (0.00%) | 32.12 | ||
| Eris Lifesciences | NA (0.00%) | 54.10 |